Marc-Andre Lebel
Chief Executive Officer at FRX INNOVATIONS INC.
Profile
Marc-Andre Lebel founded Anapharm, Inc. in 1994, where he worked as President from 1994 to 2007 and FRX Polymers, Inc. in 2007, where he is working as President & Chief Executive Officer from 2007.
Dr. Lebel also founded Sensera, Inc., where he worked as Chief Financial Officer.
Dr. Lebel also currently works at FRX Innovations, Inc., as President, Chief Executive Officer & Director, NuChem Sciences, Inc., as Chairman & President from 2017, Nuchem, Inc., as Independent Director, and Laurent Pharmaceuticals, Inc., as Director.
Dr. Lebel also formerly worked at Warnex, Inc., as Chief Executive Officer & Director from 2012 to 2013, DSM Thermoplastic Elastomers, Inc., as Chief Executive Officer, Cabot Corp., as Group Director-Global Business, Acasti Pharma, Inc., as Director in 2011, Asmacure Ltée, as Director, Nuchem Therapeutics, Inc., as President & Director, inVentiv Health Clinical, Inc., as Senior Vice President from 2005 to 2007, Aspen Aerogels, Inc., as Vice President-Sales & Marketing, PharmaNet, Inc., as Executive Vice President in 2007, and Triton Systems, Inc., as Executive Vice President.
Dr. Lebel received his undergraduate degree from the University of Ottawa.
Marc-Andre Lebel active positions
| Companies | Position | Start |
|---|---|---|
| FRX INNOVATIONS INC. | Chief Executive Officer | - |
Laurent Pharmaceuticals, Inc.
 Laurent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Laurent Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops clinical stage, orally-active drug candidate with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. The company was founded in 2012 and is headquartered in Montr?al, Canada. | Director/Board Member | - |
| Nuchem, Inc. | Director/Board Member | - |
FRX Polymers, Inc.
 FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | Chief Executive Officer | 2006-12-31 |
NuChem Sciences, Inc.
 NuChem Sciences, Inc. BiotechnologyHealth Technology Part of Sygnature Discovery Ltd., NuChem Sciences, Inc. was founded in 2011 and is a leading contract research organization in drug discovery and chemical development. The private company is based in Saint-Laurent, Canada. NuChem Sciences, which employs 300 scientific and support staff, offers a range of standalone and integrated discovery services in chemistry, biochemistry, in-vitro biology, DMPK, structural biology, and in vivo pharmacology. NuChem Sciences' expert chemistry services for drug discovery feature synthetic, medicinal, and analytical solutions. The Canadian company also offers advanced ADME studies, metabolic stability analysis, and tailored solutions for drug discovery. NuChem Sciences was acquired by Sygnature Discovery Ltd. on July 31, 2023. | Chairman | 2017-05-31 |
Former positions of Marc-Andre Lebel
| Companies | Position | End |
|---|---|---|
| WARNEX INC. | Chief Executive Officer | 2013-04-28 |
Anapharm, Inc.
 Anapharm, Inc. Miscellaneous Commercial ServicesCommercial Services Anapharm, Inc. is a hospital and health care company. It provides clinical trials and bioanalytical research services. The company is headquartered in Québec, Canada. | Founder | 2007-03-17 |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 2007-03-17 |
PharmaNet, Inc.
 PharmaNet, Inc. Medical DistributorsDistribution Services PharmaNet, Inc. researches and develops new drugs and provides clinical development & consulting services. Its services include strategic planning, data management, bio-statistics, site management, study monitoring, protocol/CRF design, project management, information technology, quality control and assurance and regulatory affairs. The company was founded in 1996 by Jeffrey P. McMullen and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 2006-12-31 |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Marc-Andre Lebel
| University of Ottawa | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ACASTI PHARMA INC. | Health Technology |
| ASPEN AEROGELS, INC. | Process Industries |
| CABOT CORPORATION | Process Industries |
| FRX INNOVATIONS INC. | Process Industries |
| Private companies | 13 |
|---|---|
Anapharm, Inc.
Anapharm, Inc. Miscellaneous Commercial ServicesCommercial Services Anapharm, Inc. is a hospital and health care company. It provides clinical trials and bioanalytical research services. The company is headquartered in Québec, Canada. | Commercial Services |
FRX Polymers, Inc.
FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | Process Industries |
Triton Systems, Inc.
 Triton Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Triton Systems, Inc. provides technology products development services. The firm's products include air drop platforms, bed net tents, electronic enclosures, FRA composites, invexus surface treatments, and traceptors preconcentrator. The company was founded by Ross R. Haghighat in 1992 and is headquartered in Chelmsford, MA. | Commercial Services |
DSM Thermoplastic Elastomers, Inc.
 DSM Thermoplastic Elastomers, Inc. Chemicals: SpecialtyProcess Industries Part of DSM BV, DSM Thermoplastic Elastomers, Inc. is a private company based in MA. | Process Industries |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Commercial Services |
| Nuchem, Inc. | |
Warnex, Inc.
 Warnex, Inc. Medical SpecialtiesHealth Technology Warnex, Inc. engages as a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical sector. The company was founded on January 4, 1996 and is headquartered in Laval, Canada. | Health Technology |
Sensera, Inc.
 Sensera, Inc. SemiconductorsElectronic Technology Part of Johnson & Johnson, Sensera, Inc. is a private company that manufactures sensors and modules. The company is based in Woburn, MA. The company was founded by Marc-Andre Lebel. Sensera was acquired by ABIOMED, Inc., a subsidiary of Johnson & Johnson from Sensera Ltd. on January 04, 2022 for $7.50 million. | Electronic Technology |
Asmacure Ltée
 Asmacure Ltée Pharmaceuticals: MajorHealth Technology Asmacure Ltée develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases. The company was founded by Yvon Cormier and Evelyne Israel-Assayag in 2002 and is headquartered in Quebec, Canada. | Health Technology |
PharmaNet, Inc.
PharmaNet, Inc. Medical DistributorsDistribution Services PharmaNet, Inc. researches and develops new drugs and provides clinical development & consulting services. Its services include strategic planning, data management, bio-statistics, site management, study monitoring, protocol/CRF design, project management, information technology, quality control and assurance and regulatory affairs. The company was founded in 1996 by Jeffrey P. McMullen and is headquartered in Princeton, NJ. | Distribution Services |
Nuchem Therapeutics, Inc.
 Nuchem Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nuchem Therapeutics, Inc. provides financial investment services. The firm offers medicinal chemistry services and expertise, biochemistry support, custom and contract synthesis and assay development. The company was founded in 2011 and is headquartered in Montreal, Canada. | Commercial Services |
Laurent Pharmaceuticals, Inc.
Laurent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Laurent Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops clinical stage, orally-active drug candidate with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. The company was founded in 2012 and is headquartered in Montr?al, Canada. | Health Technology |
NuChem Sciences, Inc.
NuChem Sciences, Inc. BiotechnologyHealth Technology Part of Sygnature Discovery Ltd., NuChem Sciences, Inc. was founded in 2011 and is a leading contract research organization in drug discovery and chemical development. The private company is based in Saint-Laurent, Canada. NuChem Sciences, which employs 300 scientific and support staff, offers a range of standalone and integrated discovery services in chemistry, biochemistry, in-vitro biology, DMPK, structural biology, and in vivo pharmacology. NuChem Sciences' expert chemistry services for drug discovery feature synthetic, medicinal, and analytical solutions. The Canadian company also offers advanced ADME studies, metabolic stability analysis, and tailored solutions for drug discovery. NuChem Sciences was acquired by Sygnature Discovery Ltd. on July 31, 2023. | Health Technology |
- Stock Market
- Insiders
- Marc-Andre Lebel